COPD exacerbations: defining their cause and prevention

被引:813
|
作者
Wedzicha, Jadwiga A.
Seemungal, Terence A. R.
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Acad Unit Resp Med, London NW3 2PF, England
[2] UCL, London, England
[3] Univ W Indies, Dept Clin Med Sci, St Augustine, Trinidad Tobago
来源
LANCET | 2007年 / 370卷 / 9589期
关键词
D O I
10.1016/S0140-6736(07)61382-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 50 条
  • [1] RSV as a Cause of Exacerbations of COPD
    Wiseman, Dexter
    Thwaites, Ryan
    Macleod, Mairi
    Ritchie, Andrew
    Finney, Lydia
    Kamal, Faisal
    Shahbakhti, Hasan
    Uruchurtu, Ashley Sanchez Sevilla
    Aaron, Braddy-Green
    Allinson, James
    Donaldson, Gavin
    Openshaw, Peter
    Wedzicha, Jadwiga
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] Towards precision in defining COPD exacerbations
    Jenkins, Christine R.
    BREATHE, 2021, 17 (03)
  • [3] Azithromycin for Prevention of Exacerbations of COPD
    Albert, Richard K.
    Connett, John
    Bailey, William C.
    Casaburi, Richard
    Cooper, J. Allen D., Jr.
    Criner, Gerard J.
    Curtis, Jeffrey L.
    Dransfield, Mark T.
    Han, MeiLan K.
    Lazarus, Stephen C.
    Make, Barry
    Marchetti, Nathaniel
    Martinez, Fernando J.
    Madinger, Nancy E.
    McEvoy, Charlene
    Niewoehner, Dennis E.
    Porsasz, Janos
    Price, Connie S.
    Reilly, John
    Scanlon, Paul D.
    Sciurba, Frank C.
    Scharf, Steven M.
    Washko, George R.
    Woodruff, Prescott G.
    Anthonisen, Nicholas R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 689 - 698
  • [4] Benralizumab for the Prevention of COPD Exacerbations
    Criner, G. J.
    Celli, B. R.
    Brightling, C. E.
    Agusti, A.
    Papi, A.
    Singh, D.
    Sin, D. D.
    Vogelmeier, C. F.
    Sciurba, F. C.
    Bafadhel, M.
    Backer, V
    Kato, M.
    Ramirez-Venegas, A.
    Wei, Y-F
    Bjermer, L.
    Shih, V. H.
    Jison, M.
    O'Quinn, S.
    Makulova, N.
    Newbold, P.
    Goldman, M.
    Martin, U. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (11): : 1023 - 1034
  • [5] PREVENTION AND TREATMENT OF COPD EXACERBATIONS
    Lee, J. S.
    RESPIROLOGY, 2015, 20 : 3 - 3
  • [6] Management and prevention of exacerbations of COPD
    Aaron, Shawn D.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [7] COPD exacerbations • 4:: Prevention
    Scott, S
    Walker, P
    Calverley, PMA
    THORAX, 2006, 61 (05) : 440 - 447
  • [8] Azithromycin for Prevention of Exacerbations of COPD
    Hahn, David L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2235 - 2236
  • [9] COPD exacerbations: impact and prevention
    Wedzicha, Jadwiga A.
    Mackay, Alex J.
    Singh, Richa
    BREATHE, 2013, 9 (06) : 435 - 440
  • [10] Prevention of exacerbations of COPD with pharmacotherapy
    Miravitlles, M.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (116): : 119 - 126